This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Msn Laboratories Private Limited, R&d Center. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Markandeya Bekkam: Innovator in Pharmaceutical Chemistry
Introduction
Markandeya Bekkam is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug formulations. With a total of 2 patents, his work has the potential to impact the pharmaceutical industry positively.
Latest Patents
Markandeya's latest patents include the development of solid-state forms of 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1H,3H)-dione hydrochloride. This invention relates to the preparation processes of this compound and an improved method for its synthesis. Additionally, he has provided an amorphous polymorph of a combination drug consisting of 2'-deoxy-5-(trifluoromethyl) uridine and 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1H,3H)-dione monohydrochloride, along with its preparation process. Another significant patent involves the preparation of 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole and its polymorphs, including the salts of this compound and their preparation methods.
Career Highlights
Markandeya Bekkam is currently associated with Msn Laboratories Private Limited, R&D Center. His role in this organization allows him to explore and innovate within the pharmaceutical sector, contributing to the development of new therapeutic solutions.
Collaborations
He has collaborated with notable coworkers such as Thirumalai Rajan Srinivasan and Eswaraiah Sajja, enhancing the research and development efforts at Msn Laboratories.
Conclusion
Markandeya Bekkam's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his role as an innovator in the field. His work continues to pave the way for advancements in drug formulation and preparation processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile